RPTX Stock Analysis: Buy, Sell, or Hold?
RPTX - Repare Therapeutics Inc. Common Shares
$2.65
0.02 (0.76%)
▲
5d:
+2.71%
30d:
+3.31%
90d:
+35.2%
BUY
MODERATE Confidence
Analysis Updated: Jan 27, 2026 12:00 AM ET
Earnings: May 12, 2026
2d
Get Alerted When RPTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: RPTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: RPTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: RPTX is currently trading at $2.65, which is considered fair based on recent price action.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RPTX is in a strong uptrend. The price is approaching resistance at $2.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
57/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
66.8%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Trading below Wall St target ($3.00)
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$2.65
Current Trend
Strong Uptrend
Technical data as of
Jan 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.63
Wall Street Target
$3.00
(+13.2%)
Revenue Growth (YoY)
-76.7%
Share & Embed Analysis
Last updated: May 09, 2026 9:14 AM ET
Data refreshes hourly during market hours. Next update: 10:14 AM
Data refreshes hourly during market hours. Next update: 10:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RPTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 56 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$131 | 48 HOLD |
